Vaccine Insights

VACCINE INSIGHTS

October 2024

Vaccine Insights Vol 3 Issue 6
View Issue

Vol 3 Issue 6

Spotlight: RNA vaccines: formulation & production

View Spotlight

Upcoming webinars

Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

Rok Sekirnik
3 December
in 13
Days
Register
Faster, smaller, smarter: intelligent manufacturing of mRNA through the power of process analytical technologies

Faster, smaller, smarter: intelligent manufacturing of mRNA through the power of process analytical technologies

Aaron Cowley, Edita Botonjic-Sehic
11 December
in 21
Days
Register
View all webinars

Latest Articles

Strengthening cold chain maintenaance systems in resource-constrained environments: insights from Nigeria

Strengthening cold chain maintenaance systems in resource-constrained environments: insights from Nigeria

Tahir Buhari
19 November
Spotlight on RNA vaccines: formulation and production

Spotlight on RNA vaccines: formulation and production

Iulia Oita
7 November
Navigating the mRNA-LNP patent labyrinth: advice for developers

Navigating the mRNA-LNP patent labyrinth: advice for developers

Dan Shores
7 November
History is the best teacher: what can RNA manufacturers learn from the challenges and successes of traditional biologics?

History is the best teacher: what can RNA manufacturers learn from the challenges and successes of traditional biologics?

Adam Brown
1 November
Understanding DNA starting material for mRNA production

Understanding DNA starting material for mRNA production

Lawrence Thompson
30 October
The effects of different causes of immunodeficiency on vaccine efficacy against infectious diseases: some lessons from COVID

The effects of different causes of immunodeficiency on vaccine efficacy against infectious diseases: some lessons from COVID

Jeremy S Brown
9 October
Developing new RNA vaccine formulations to target non-enveloped viruses and boost mucosal responses

Developing new RNA vaccine formulations to target non-enveloped viruses and boost mucosal responses

Jesse Erasmus
9 October
Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics

Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics

June Kim, Anna Särnefält
9 October
Bag-to-bag consistency: homogeneous cell count distribution in biopharmaceutical aliquotation

Bag-to-bag consistency: homogeneous cell count distribution in biopharmaceutical aliquotation

Alexander Fuchs
6 October